Kerry Bozza Funkhouser at BIC 2025 Roundtable on Heavy Menstrual Bleeding and Rare Bleeding Disorders
Kerry Bozza Funkhouser, the Executive Director for the Foundation for Women & Girls with Blood Disorders, has shared a post on LinkedIn:
“Thrilled to share I’ll be joining Dr. Amy Shapiro, Dr. Giancarlo Castaman, and Dr. Anna Maria Fulghesu on September 11, preceding the 13th BIC International Conference (Sept 12–14 in Padua, Italy) for a roundtable discussion on heavy menstrual bleeding (HMB) in adolescents and rare bleeding disorders. HMB is common, but when it hides an underlying bleeding disorder, early recognition is critical.
This session will bring together multiple specialties and education/advocacy voices to explore best practices for timely diagnosis and effective management. Many thanks to Hemorare for the invitation to contribute to this important dialogue.”
You can learn more about the program here.
Discover more on Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning